| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
79,422 |
68,007 |
$5.18M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
42,870 |
39,098 |
$4.25M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
19,952 |
18,709 |
$2.66M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13,896 |
13,022 |
$1.78M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13,040 |
11,677 |
$1.47M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
48,798 |
46,270 |
$942K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,120 |
5,521 |
$709K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,170 |
6,566 |
$450K |
| 97802 |
|
37,071 |
35,215 |
$387K |
| 90461 |
|
26,178 |
24,626 |
$255K |
| 99383 |
|
953 |
918 |
$123K |
| 99188 |
|
9,377 |
8,484 |
$96K |
| 99382 |
|
300 |
296 |
$46K |
| 92558 |
|
26,178 |
23,673 |
$44K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,351 |
2,101 |
$36K |
| 99384 |
|
244 |
239 |
$33K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,307 |
2,939 |
$31K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,685 |
3,213 |
$27K |
| 99381 |
|
290 |
244 |
$27K |
| 90686 |
|
14,322 |
13,487 |
$27K |
| 85018 |
|
21,336 |
20,022 |
$16K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
554 |
443 |
$14K |
| 83655 |
|
5,049 |
4,801 |
$13K |
| 96160 |
|
37,288 |
35,647 |
$12K |
| 90716 |
|
3,482 |
3,308 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
156 |
152 |
$7K |
| 90633 |
|
5,512 |
5,187 |
$6K |
| 0071A |
|
152 |
135 |
$6K |
| 90670 |
|
11,592 |
11,080 |
$6K |
| 90707 |
|
5,231 |
4,978 |
$5K |
| 90723 |
|
6,906 |
6,665 |
$3K |
| 90648 |
|
11,619 |
11,122 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
442 |
429 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$2K |
| 36416 |
|
29,089 |
25,852 |
$2K |
| 90651 |
|
2,352 |
2,214 |
$1K |
| 80061 |
Lipid panel |
3,059 |
2,984 |
$1K |
| 0001A |
|
17 |
16 |
$643.14 |
| 91307 |
|
318 |
255 |
$542.72 |
| 0072A |
|
15 |
15 |
$501.16 |
| 90734 |
|
670 |
654 |
$461.72 |
| 87807 |
|
141 |
138 |
$427.02 |
| 99072 |
|
78,202 |
62,025 |
$313.34 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,467 |
5,100 |
$300.00 |
| 96127 |
|
468 |
412 |
$292.89 |
| 90700 |
|
201 |
199 |
$250.54 |
| 99173 |
|
17,719 |
15,105 |
$218.44 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
56 |
53 |
$186.89 |
| A4928 |
Surgical mask, per 20 |
663 |
620 |
$162.92 |
| 90696 |
|
105 |
99 |
$157.37 |
| 36415 |
Collection of venous blood by venipuncture |
47 |
47 |
$145.00 |
| 92567 |
|
39 |
36 |
$128.55 |
| 90681 |
|
1,897 |
1,847 |
$84.02 |
| 91300 |
|
14 |
14 |
$77.61 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
57 |
56 |
$71.36 |
| 88720 |
|
50 |
26 |
$23.80 |
| S9451 |
Exercise classes, non-physician provider, per session |
37,876 |
34,238 |
$19.03 |
| 82962 |
|
12 |
12 |
$18.20 |
| 81002 |
|
24 |
24 |
$12.54 |
| 94760 |
|
45 |
43 |
$7.26 |
| 3078F |
|
2,670 |
2,467 |
$0.00 |
| 90715 |
|
88 |
86 |
$0.00 |
| 86703 |
|
12 |
12 |
$0.00 |
| 3074F |
|
2,680 |
2,476 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
68 |
55 |
$0.00 |
| 90620 |
|
25 |
25 |
$0.00 |
| 92587 |
|
53 |
53 |
$0.00 |
| S8301 |
Infection control supplies, not otherwise specified |
18 |
14 |
$0.00 |
| 90688 |
|
12 |
12 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
46 |
44 |
$0.00 |